If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...

A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD). A recent review revisited the ...

Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system. The SUN-101/eFlow system, described as a ...

近日，优锐医药（Nuance Pharma）宣布恩司芬群Ensifentrine在中国开展的COPD三期临床试验ENHANCE-CHINA取得积极顶线结果。 该药于2024年6月首次在美国获批上市，是COPD治疗领域近20年以来首个获批上市的新机制吸入制剂，上市8个月累计销售额已达到1.14亿美元。 ENHANCE-CHINA ...

Inhalers and nebulizers are necessary when managing chronic obstructive pulmonary disease (COPD). Both are designed to deliver medication directly to the lungs, which helps in reducing symptoms, ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

An FDA complete response letter (CRL) for the chronic obstructive pulmonary disease (COPD) therapy SUN-101 (glycopyrrolate) and the Eflow nebulizer used to deliver it is sending Sunovion ...

For individuals living with COPD, small changes may make a difference. Viatris Inc. and Theravance Biopharma US, Inc. COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung ...

COPD stands for chronic obstructive pulmonary disease. The condition causes lung inflammation that leads to airflow blockage and breathing problems. [1] “COPD encompasses both emphysema and chronic ...